Advertisement
Screener

Immunoclin Corp Forms 3, 4 and 5: Preferred Stock

Immunoclin Corp Forms 3, 4 and 5: Preferred Stock

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows, 14 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2016-04-01: Reporting owner Castor Management Services Inc.; Form 3; Security Series A Preferred Stock; Transaction Holding.
  • 2015-06-18: Reporting owner Bray DH; Form 3/A; Security Series A Preferred Stock; Transaction Holding.
  • 2015-06-18: Reporting owner Bray DH; Form 4/A; Security Series A Preferred Stock; Transaction Holding.
  • 2015-06-18: Reporting owner Bray DH; Form 4/A; Security Series A Preferred Stock; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2016-04-01
holding as of filing
Castor Management Services Inc.
10% Owner
3Series A Preferred Stock
Non-derivative · Direct
Holding
500,000 owned after
no price filed2016-04-01
2015-06-18
holding as of filing
Bray DH
Director, Officer (President, CEO), 10% Owner
3/ASeries A Preferred Stock
Non-derivative · Indirect · (m)
Holding
370,000 owned after
no price filed2015-06-18
2015-06-18
holding as of filing
Bray DH
Director, Officer (President, CEO), 10% Owner
4/ASeries A Preferred Stock
Non-derivative · Indirect · (m)
Holding
370,000 owned after
no price filed2015-06-18
2015-06-18
holding as of filing
Bray DH
Director, Officer (President, CEO), 10% Owner
4/ASeries A Preferred Stock
Non-derivative · Indirect · (m)
Holding
370,000 owned after
no price filed2015-06-18
2015-06-12
holding as of filing
Benlhassan Khadija
Director, Officer (Chief Scientific Officer)
4Series A Preferred Stock
Non-derivative · Indirect · Held by KBLH Holding BV, a company which Dr. Benlhassan has voting and investment control over
Holding
100,000 owned after
no price filed2015-06-12
2015-06-09
holding as of filing
Bray DH
Director, Officer (President, CEO), 10% Owner
4Series A Preferred Stock
Non-derivative · Indirect · (m)
Holding
370,000 owned after
no price filed2015-06-09
2015-06-09
holding as of filing
JOHNSON CHAD STEVEN
Director, Officer (Secretary/COO/General Counsel)
4Series A Preferred Stock
Non-derivative · Indirect · Held by CSJ Group LLC, a company which Mr. Johnson has voting and investment control over.
Holding
30,000 owned after
no price filed2015-06-09
2015-02-06
holding as of filing
Dabney Raymond C.
10% Owner
3Series A Preferred Stock
Non-derivative · Direct
Holding
500,000 owned after
no price filed2015-02-06
2015-01-30Castor Management Services Inc.
10% Owner
4Series A Preferred Stock
Non-derivative · Direct
S Open market or private sale of non-derivative or derivative security−500,000
0 owned after
$0.002016-04-01
2015-01-15
holding as of filing
JOHNSON CHAD STEVEN
Director, Officer (Secretary/COO/General Counsel)
4Series A Preferred Stock
Non-derivative · Indirect · (m)
Holding
30,000 owned after
no price filed2015-01-15
2014-11-06
holding as of filing
Bray DH
Director, Officer (President, C.E.O.), 10% Owner
4Series A Preferred Stock
Non-derivative · Indirect · (m)
Holding
370,000 owned after
no price filed2014-11-06
2014-10-16
holding as of filing
Bray DH
Director, Officer (President, C.E.O.), 10% Owner
3Series A Preferred Stock
Non-derivative · Indirect · (m)
Holding
370,000 owned after
no price filed2014-10-16
2014-10-14
holding as of filing
Benlhassan Khadija
Director, Officer (Chief Scientific Officer)
3Series A Preferred Stock
Non-derivative · Direct
Holding
100,000 owned after
no price filed2014-10-14
2014-10-09
holding as of filing
JOHNSON CHAD STEVEN
Director, Officer (COO, Secretary, Gen. Counsel), 10% Owner
3Series A Preferred Stock
Non-derivative · Indirect · (m)
Holding
30,000 owned after
no price filed2014-10-09